Bumper Offer - Urjas oil Just @ Rs. 1
Trajenta is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Diabetes.
Medical history of the patient along with age and gender determines the dosage of Trajenta. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The most common side effects of Trajenta are Headache, Anxiety, Blurred vision. Besides the aforementioned side effects, there are other adverse effects of Trajenta as well, which are listed below. These side effects of Trajenta are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Trajenta's effect during pregnancy is Severe and Severe while nursing. Warnings related to Trajenta's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Diabetes Type 1, Diabetic Ketoacidosis, Pancreatitis must refrain from the use of Trajenta since this can cause severe adverse effects. Other conditions have been mentioned below in the Trajenta contraindications section.
Drug interactions for Trajenta have been reported in the medical literature. Refer to the list below for further details.
In addition to these precautions, you may also note that Trajenta is safe while driving, and is is addictive in nature.
Trajenta is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Trajenta is used -
Moderate
Common
Is the use of Trajenta safe for pregnant women?
Trajenta should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Trajenta safe during breastfeeding?
Women who are breastfeeding, may experience serious side effects after taking Trajenta. So it is adviced to consult the doctor before using it.
What is the effect of Trajenta on the Kidneys?
Kidney can be affected by Trajenta. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Trajenta on the Liver?
The liver can be affected by Trajenta. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Trajenta only after medical advice.
What is the effect of Trajenta on the Heart?
Trajenta is rarely harmful for the heart.
Trajenta should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Trajenta unless your doctor advises you to do so -
Is this Trajenta habit forming or addictive?
Trajenta does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Trajenta will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Trajenta is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, Trajenta cannot treat any kind of mental disorder.
Interaction between Food and Trajenta
Due to a lack of research, nothing can be said about the consequences of taking Trajenta together with food.
Interaction between Alcohol and Trajenta
Side effects of drinking alcohol and taking Trajenta at the same time are rare and minor. However, if you face any side effects, talk to your doctor immediately.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 776
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tradjenta™ (linagliptin)